4.8 Article

Dopamine neuron glutamate cotransmission evokes a delayed excitation in lateral dorsal striatal cholinergic interneurons

Journal

ELIFE
Volume 7, Issue -, Pages -

Publisher

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.39786

Keywords

-

Categories

Funding

  1. National Institute on Drug Abuse [R01 DA038966, R21 DA040443]
  2. National Institute of Mental Health [T32 MH19970, R01 MH113569, R01 MH110556]
  3. National Institute of Neurological Disorders and Stroke [R01 NS101982]

Ask authors/readers for more resources

Dopamine neurons have different synaptic actions in the ventral and dorsal striatum (dStr), but whether this heterogeneity extends to dStr subregions has not been addressed. We have found that optogenetic activation of dStr dopamine neuron terminals in mouse brain slices pauses the firing of cholinergic interneurons in both the medial and lateral subregions, while in the lateral subregion the pause is shorter due to a subsequent excitation. This excitation is mediated mainly by metabotropic glutamate receptor 1 (mGluR1) and partially by dopamine D1-like receptors coupled to transient receptor potential channel 3 and 7. DA neurons do not signal to spiny projection neurons in the medial dStr, while they elicit ionotropic glutamate responses in the lateral dStr. The DA neurons mediating these excitatory signals are in the substantia nigra (SN). Thus, SN dopamine neurons engage different receptors in different postsynaptic neurons in different dStr subregions to convey strikingly different signals.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice

Myoung Seok Ko, Ji Young Yun, In-Jeoung Baek, Jung Eun Jang, Jung Jin Hwang, Seung Eun Lee, Seung-Ho Heo, David A. Bader, Chul-Ho Lee, Jaeseok Han, Jong-Seok Moon, Jae Man Lee, Eun-Gyoung Hong, In-Kyu Lee, Seong Who Kim, Joong Yeol Park, Sean M. Hartig, Un Jung Kang, David D. Moore, Eun Hee Koh, Ki-up Lee

Summary: This study revealed the role of a specific gene, pink1, in mitochondrial autophagy, where its deficiency induces dysfunction in brown adipose tissue and obesity. Surprisingly, the induction of NLRP3 did not lead to canonical inflammasome activity, but instead caused brown adipocyte precursors to differentiate into white-like adipocytes. These findings suggest a new mitochondria-NLRP3 pathway that contributes to BAT dysfunction and provide potential therapeutic targets for obesity-related metabolic diseases.

AUTOPHAGY (2021)

Article Neurosciences

Vulnerable and Resilient Phenotypes in a Mouse Model of Anorexia Nervosa

Jeff A. Beeler, Devry Mourra, Roseanna M. Zanca, Abigail Kalmbach, Celia Gellman, Benjamin Y. Klein, Rebecca Ravenelle, Peter Serrano, Holly Moore, Stephen Rayport, Susana Mingote, Nesha S. Burghardt

Summary: The rodent model of anorexia nervosa shows distinct resilient and vulnerable phenotypes, with dopamine playing a central role in modulating susceptibility.

BIOLOGICAL PSYCHIATRY (2021)

Article Clinical Neurology

A rapid α-synuclein seed assay of Parkinson's disease CSF panel shows high diagnostic accuracy

Christina D. Orru, Thong C. Ma, Andrew G. Hughson, Bradley R. Groveman, Ankit Srivastava, Douglas Galasko, Rachel Angers, Patrick Downey, Karen Crawford, Samantha J. Hutten, Un Jung Kang, Byron Caughey

Summary: The study shows that an improved assay for diagnosing Parkinson's disease dramatically reduces the diagnosis time while maintaining high performance standards. Positive signals were found in 97% of Parkinson's disease cases compared to only 13% of healthy controls, with weak correlations between assay parameters and clinical measures observed. The assay's efficiency in diagnosing Parkinson's disease is supported by these findings.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Editorial Material Neurosciences

COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel?

Bastiaan R. Bloem, Claudia Trenkwalder, Alvaro Sanchez-Ferro, Lorraine V. Kalia, Roy Alcalay, Han-Lin Chiang, Un Jung Kang, Christopher Goetz, Patrik Brundin, Stella M. Papa

Summary: Despite concerns raised by people with Parkinson's disease (PD) and their physicians regarding the efficacy and safety of COVID-19 vaccines in the specific context of PD and its treatment, current literature and experience with widespread vaccination suggest that COVID-19 vaccination with approved vaccines is recommended for PD patients, unless there is a specific contraindication.

JOURNAL OF PARKINSONS DISEASE (2021)

Article Clinical Neurology

α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy

Suman Dutta, Simon Hornung, Adira Kruayatidee, Katherine N. Maina, Irish del Rosario, Kimberly C. Paul, Darice Y. Wong, Aline Duarte Folle, Daniela Markovic, Jose-Alberto Palma, Geidy E. Serrano, Charles H. Adler, Susan L. Perlman, Wayne W. Poon, Un Jung Kang, Roy N. Alcalay, Miriam Sklerov, Karen H. Gylys, Horacio Kaufmann, Brent L. Fogel, Jeff M. Bronstein, Beate Ritz, Gal Bitan

Summary: The study found that measuring α-syn in exosomes from blood can effectively distinguish between patients with PD and MSA with high sensitivity and specificity. A multinomial logistic model combining α-syn concentration, exosome concentration, and a ratio between α-syn concentrations in specific exosomes showed promising results in separating PD from MSA.

ACTA NEUROPATHOLOGICA (2021)

Review Neurosciences

Dopamine Neurons That Cotransmit Glutamate, From Synapses to Circuits to Behavior

Daniel Eskenazi, Lauren Malave, Susana Mingote, Leora Yetnikoff, Samira Ztaou, Vlad Velicu, Stephen Rayport, Nao Chuhma

Summary: Dopamine neurons have the ability to cotransmit glutamate, playing significant roles in neuroprotection, behavioral responses, and neuropsychiatric disorders.

FRONTIERS IN NEURAL CIRCUITS (2021)

Review Behavioral Sciences

Where Dopaminergic and Cholinergic Systems Interact: A Gateway for Tuning Neurodegenerative Disorders

Marianne Amalric, Tommy Pattij, Ioannis Sotiropoulos, Joana M. Silva, Nuno Sousa, Samira Ztaou, Cristiano Chiamulera, Lars U. Wahlberg, Dwaine F. Emerich, Giovanna Paolone

Summary: Historically, studies on neurodegenerative diseases have largely examined alterations in specific neuronal populations, but it is becoming increasingly clear that the integrity of multiple interconnected neuronal circuits regulates various brain activities in mammals. The dopaminergic and cholinergic systems play crucial roles in orchestrating cognitive and non-cognitive symptoms in PD and AD.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2021)

Article Neurosciences

Single Dose of Amphetamine Induces Delayed Subregional Attenuation of Cholinergic Interneuron Activity in the Striatum

Samira Ztaou, Soo Jung Oh, Sophia Tepler, Sixtine Fleury, Miriam Matamales, Jesus Bertran-Gonzalez, Nao Chuhma, Stephen Rayport

Summary: This study demonstrates that a single dose of amphetamine has delayed regionally heterogeneous effects on cholinergic interneuron activity, which likely involves extra-striatal synaptic input.

ENEURO (2021)

Article Clinical Neurology

mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis

Jose-Alberto Palma, Jose Martinez, Patricio Millar Vernetti, Thong Ma, Miguel A. Perez, Judy Zhong, Yingzhi Qian, Suman Dutta, Katherine N. Maina, Ibrar Siddique, Gal Bitan, Benjamin Ades-Aron, Timothy M. Shepherd, Un J. Kang, Horacio Kaufmann

Summary: The efficacy and safety of sirolimus in patients with multiple system atrophy (MSA) were investigated in this study. The results showed that sirolimus treatment for 48 weeks was futile in slowing the progression of MSA and had no effect on biomarkers compared to placebo. Changes in blood neurofilament light chain (NfL) and whole brain atrophy were identified as promising biomarkers of disease progression for future clinical trials.

MOVEMENT DISORDERS (2022)

Article Cell Biology

Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins

Milagros Pereira Luppi, Maite Azcorra, Giuliana Caronia-Brown, Jean-Francois Poulin, Zachary Gaertner, Serafin Gatica, Oscar Andres Moreno-Ramos, Navid Nouri, Marilyn Dubois, Yongchao C. Ma, Charu Ramakrishnan, Lief Fenno, Yoon Seok Kim, Karl Deisseroth, Francesca Cicchetti, Daniel A. Dombeck, Rajeshwar Awatramani

Summary: The study found that Sox6 expression distinguishes ventrally and dorsally biased dopamine (DA) neuron populations in the substantia nigra pars compacta (SNc), showing distinct molecular profiles, projections, and functions. This adult division was encoded early in development.

CELL REPORTS (2021)

Editorial Material Neurosciences

Editorial: Dopamine Neuron Diversity in Circuits and Diseases

Jean-Francois Poulin, Talia Newcombe Lerner, Mark W. Howe

FRONTIERS IN NEURAL CIRCUITS (2022)

Article Neurosciences

Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson's disease phenotypes

Giulietta Maria Riboldi, Marco J. Russo, Ling Pan, Kristen Watkins, Un Jung Kang

Summary: Non-motor symptoms like dysautonomia and REM sleep behavior disorder in Parkinson's disease may indicate different types of the disease. Through analysis of data from newly diagnosed Parkinson's patients, it was found that dysautonomia symptoms can predict disease progression more accurately.

NPJ PARKINSONS DISEASE (2022)

Correction Neurosciences

Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson's disease phenotypes (vol 8, 110, 2022)

Giulietta Maria Riboldi, Marco J. Russo, Ling Pan, Kristen Watkins, Un Jung Kang

NPJ PARKINSONS DISEASE (2023)

Article Clinical Neurology

Substantia Nigra Pars Reticulata Projections to the Pedunculopontine Nucleus Modulate Dyskinesia

Yong Hu, Thong C. Ma, Stephanie L. Alberico, Yunmin Ding, Lingjing Jin, Un Jung Kang

Summary: This study aimed to determine whether direct modulation of SNr GABAergic neurons and SNr projections to the PPN can regulate PD symptoms and levodopa-induced dyskinesia (LID). The results showed that suppressing SNr neuron activity improved akinesia, while increasing SNr neuronal activity significantly reduced LID. The projections from SNr to PPN likely mediate the antidyskinetic effect of increasing SNr neuronal activity.

MOVEMENT DISORDERS (2023)

No Data Available